Filbrandt Wealth Management’s AbbVie ABBV Stock Holding History

Filbrandt Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$174K	Buy	1,610 +15	+0.9%	+$1.71K	0.1%	40
2021 Q2	$180K	Hold	1,595	–	–	0.1%	42
2021 Q1	$173K	Hold	1,595	–	–	0.1%	40
2020 Q4	$171K	Hold	1,595	–	–	0.11%	37
2020 Q3	$140K	Sell	1,595 -560	-26%	-$52.7K	0.11%	37
2020 Q2	$212K	Buy	2,155 +1,099	+104%	+$96.8K	0.17%	38
2020 Q1	$80K	Buy	1,056 +56	+6%	+$4.77K	0.09%	49
2019 Q4	$88K	Buy	+1,000	New	+$83K	0.08%	54

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Filbrandt Wealth Management's ABBV Position: Q3 2021 in Review

Filbrandt Wealth Management increased its AbbVie (ABBV) stake by 0.94% in Q3 2021, buying an estimated $1.71K and bringing the position to 1,610 shares worth $174K. The position accounts for 0.1% of the portfolio, ranked #40.

Filbrandt Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 8 quarters since. The position peaked at $212K in Q2 2020. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Filbrandt Wealth Management held 1,610 shares of AbbVie worth $174K as of Q3 2021.
Filbrandt Wealth Management bought 15 AbbVie shares in Q3 2021, an estimated $1.71K.
AbbVie made up 0.1% of Filbrandt Wealth Management's portfolio in Q3 2021, its #40 holding.
Filbrandt Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 8 quarters since.
Filbrandt Wealth Management's AbbVie position peaked at $212K in Q2 2020.
2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.